Hi Larry – thanks for this important discussion. I agree with you that as consumers, we should try to learn factual information so we buy the most affordable version and still have predictable and beneficial results but also to know why the ubiquinol form may be important for those with specific health disorders.
For instance, because of my mitochondrial dysfunction as well as my age and my continual focus to reduce inflammation, I use 100 mg of the Ubiquinol form and 200 mg of the Ubiquinone; sometimes 300 mg.
In 2007, a post on an interview with Dr. Judy was offered here which may help shed some light on the actually process of absorption and benefits of CoQ10 along with reader questions and responses.
Read here: [
www.afibbers.org]
The interview mentioned the Designs for Health professional grade products and since that time, DFH has added a ubiquinol form to their product line… CoQnol which is a stabilized, reduced non GMO CoQ10 product (as Kaneka QH Ubiquinol® reduced form of CoQ10).
These clips are from the DFH product data sheet:
The body uses two forms of CoQ10. Ubiquinone, also known as the oxidized form, is better known and is used primarily for energy production in the electron transport energy cycle inside the cell. Ubiquinol plays a primary role in decreasing oxidative damage caused by lipid peroxidation within mitochondria. According to research, plasma ubiquinol is decreased in patients with hyperlipidemia.
There is evidence that suggests that the ability to convert ubiquinone to ubiquinol may diminish with age, resulting in diminished protection against oxidative stress and reduced energy levels. CoQnol™ (ubiquinol) may provide a strong initial stage defense against cellular oxidative damage and requires supplementing to maintain optimum health.
Researchers at East Texas Medical Center found that patients with advanced congestive heart failure taking high doses of ubiquinone CoQ10 were not able to achieve adequate improvements in blood serum CoQ10 levels. However, when switched to ubiquinol, blood CoQ10 levels improved dramatically with a consequential improvement in clinical symptoms and left ventricular function.
CoQ10 is also being studied for its effects on TNF alpha, and therefore on inflammation.
Consider taking CoQnol™ along with Q-Avail™ -highly absorbable ubiquinone.
CoQ10 Demystified
CoQ10 exists in both Ubiquinone and ubiquinol forms, its names derived from the word “ubiquitous” because it is present everywhere in the human body. In the mitochondrial electron transport system CoQ10 undergoes continuous reversible oxidation and reduction. It is converted to ubiquinol (reduced form) when it accepts electrons and to ubiquinone (oxidized form) when it donates electrons.1
In its ubiquinol form, CoQ10 functions as a potent antioxidant due to its ability to donate electrons, thus serving as a primary scavenger of free radicals. 1,2
Ubiquinol is the only known lipid-soluble antioxidant present in all membranes that can be synthesized endogenously (from within) by animal and human cells with an enzymatic mechanism for regeneration from ubiquinone. 3,4
Research indicates that ubiquinol is more efficient in inhibiting lipid peroxidation than alpha tocopherol, lycopene or beta-carotene.5
Ubiquinol regulates membrane fluidity, recycles radical forms of vitamins C and E and protects membrane phospholipids against peroxidation (the process whereby free radicals "steal" electrons from the lipids in cell membranes which can result in cell damage).
In addition, ubiquinol is the only known lipophilic antioxidant (having an affinity for lipids) found to be decreased in patients with liver disease.
CoQnol™ - Stablilized Reduced CoQ10
Until recently the ubiquinol form of CoQ10 was not available in a supplement. The only way to increase ubiquinol levels was to convert it from ubiquinone within the body. New technology has allowed scientists to create a stabilization process by which ubiquinol remains in its reduced form outside of the body.
Supplementing with ubiquinol, as with Designs for Health’s CoQnol,™ is an excellent way to increase levels of this wonderful antioxidant, offering superior absorption with no safety concerns. 15
Who Should Take CoQnol ™
Supplementation with CoQnol™ is ideal for those who cannot efficiently convert ubiquinone into ubiquinol, and may help support the following:
• Older individuals /People over 50
• Hyperlipidemia, including those on statin therapy (statin drugs are known to lower CoQ10 levels)
• Liver disease
• Mitochondrial disorders
• Congestive heart failure
• Aging
• Genetic CoQ10 deficiencies
• Exercise intolerance
Recommended Use:
As a dietary supplement, take one softgel per day (100 mg) with a meal, or as directed by your health care practitioner
Older individuals or anyone who suspects they have decreased CoQ10 due to oxidative stress or disease (such as those with cardio-vascular, neurological, liver- and diabetes-related conditions or those recovering from stroke) may benefit from supplementing with
CoQnol™.
Consider initially supplementing with 200-300 mg of CoQnol™ per day. After two weeks, 50-100 mg per day is recommended as a good maintenance dose.
Consider taking CoQnol™ along with QAvail™, highly absorbable ubiquinone, for comprehensive intake of CoQ10.
CoQnol™ can be taken along with Mitochondrial NRG™ for additional mitochondrial support and improvement in overall cellular and tissue vitality and health
References
Biochemical functions of coenzyme Q10. Crane FL. J Am Coll Nutr. 2001 Dec;20(6):591-8.
2. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Frei B et al. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4879-83.
3. Ubiquinol: an endogenous antioxidant in aerobic organisms. Ernster L, Forsmark-Andrée P. Clin Investig. 1993;71(8 Suppl)
60-5.
4. The antioxidant role of coenzyme Q. Bentinger M et al. Mitochondrion. 2007 Jun;7
41-50.
5. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Stocker R et al. Proc Natl
Acad Sci U S A. 1991 Mar 1;88(5):1646-50.
6. Plasma ubiquinol-10 as a marker for disease: is the assay worthwhile? Kontush A et al. Biofactors.1999;9(2-4):225-9.
7. The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Dhanasekaran M, Ren J. Curr Neurovasc
Res. 2005 Dec;2(5):447-59.
8. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-
density lipoprotein to the initiation of lipid peroxidation. Mohr D et al. Biochim Biophys Acta. 1992 Jun 26;1126:247-54.
9. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Bhagavan HN, Chopra RK. Mitochondrion. 2007 Jun;7 Suppl
78-88.
10. Age-related changes in the lipid compositions of rat and human tissues. Kalén A et al. Lipids. 1989 Jul;24(7):579-84.
11. Coenzyme Q10 in the human retina. Qu J et al. Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1814-8.
12. Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated
receptor-alpha gene expression signature in SAMP1 mice. Schmelzer C, Kubo H, Mori M, Sawashita J, Kitano M, Hosoe K, Boomgaarden I, Döring F, Higuchi
K. Mol Nutr Food Res. 2010 Jun;54(6):805-15.
13. Reduced coenzyme Q10 supplementation decelerates senescence in SAMP1 mice.
Yan J, Fujii K, Yao J, Kishida H, Hosoe K, Sawashita J, Takeda T, Mori M,
Higuchi K. Exp Gerontol. 2006 Feb;41(2):130-40. Epub 2006 Jan 4.
14. Supplemental ubiquinol in patients with advanced congestive heart failure. Langsjoen PH, Langsjoen AM. Biofactors. 208;32(1-4):119-28.
15. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Hosoe K, Kitano M,
Kishida H, Kubo H, Fujii K, Kitahara M. Regul Toxicol Pharmacol. 2007 Feb;47(1):19-28. Epub 2006 Aug 21
Jackie